Zydus Lifesciences Limited
₹922.4+0.76%Apr 13, 3:45 PM IST
ZYDUSLIFE•Health Technology•Pharmaceuticals: Major
Current Price
₹922.4+0.76%
Apr 13, 3:45 PM ISTMarket Cap₹92,115.69 Cr
Market Cap₹92,115.69 Cr
Business Overview
Zydus Lifesciences Limited operates through 2 main business divisions including Pharmaceuticals, Consumer Products.
Business Hierarchy Structure for Zydus Lifesciences Limited
- Zydus Lifesciences Limited
- Pharmaceuticals
- Formulations
- India Formulations Business
- Branded Prescription Business
- Generics
- Specialty Products
- US Formulations Business
- Generics
- Specialty Segments
- International Markets Formulations Business
- Branded Generics
- Value-added Generics
- Novel Dosage Forms
- India Formulations Business
- Active Pharmaceutical Ingredients (APIs)
- Biologics
- Novel Biologics
- Biosimilars
- Vaccines
- Specialty and Complex Generics
- Orphan Disease Space (US Specialty Business)
- New Chemical Entity (NCE) Research
- Lipaglyn™ and Bilypsa® (Saroglitazar Mg)
- Oxemia™ (Desidustat)
- Usnoflast
- ZY19489 (Anti-malarial drug)
- Therapeutic Focus Areas
- Cardiology
- Anti-Diabetes
- Respiratory
- Gynaecology
- Gastro Intestinal
- Dermatology
- Oncology
- Nephrology
- Pain Management
- Neurology
- Metabolic Disorders
- Liver Diseases
- Primary Biliary Cholangitis (PBC)
- Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Polycystic Ovary Syndrome (PCOS)
- Amyotrophic Lateral Sclerosis (ALS)
- Parkinson’s Disease
- Cryopyrin-Associated Periodic Syndromes (CAPS)
- Ulcerative Colitis (UC)
- Formulations
- Consumer Products
- Personal Care Segment
- Nycil®
- EverYuth™
- Food and Nutrition Segment
- Glucon-D®
- Complan®
- SugarFree Green™
- I’mlite™
- Nutralite™
- Personal Care Segment
- Pharmaceuticals